Decreased forelimb ability in mice intracerebroventricularly injected with low dose 6-hydroxidopamine: A model on the dissociation of bradykinesia from hypokinesia

作者：Ribeiro Renata Pietsch; Santos Danubia Bonfanti; Colle Dirleise; Naime Aline Aita; Goncalves Cinara Ludvig; Ghizoni Heloisa; Hort Mariana Appel; Godoi Marcelo; Dias Paulo Fernando; Braga Antonio Luiz; Farina Marcelo^*

来源：Behavioural Brain Research, 2016, 305: 30-36.

DOI：10.1016/j.bbr.2016.02.023

• Parkinson's disease
• 6-Hydroxidopamine
• Bradykinesia
• Hypokinesia
• Single pellet test
• Locomotor activity

Bradykinesia and hypokinesia represent well-known motor symptoms of Parkinson's disease (PD). While bradykinesia (slow execution of movements) is present in less affected PD patients and aggravates as the disease severity increases, hypokinesia (reduction of movement) seems to emerge prominently only in the more affected patients. Here we developed a model based on the central infusion of low dose (40 mu g) 6-hydroxydopamine (6-OHDA) in mice in an attempt to discriminate bradykinesia (accessed through forelimb inability) from hypokinesia (accessed through locomotor and exploratory activities). The potential beneficial effects of succinobucol against 6-OHDA-induced forelimb inability were also evaluated. One week after the beginning of treatment with succinobucol (i.p. injections, 10 mg/kg/day), mice received a single i.c.v. infusion of 6-OHDA (40 mu g/site). One week after G-OHDA infusion, general locomotor/exploratory activities (open field test), muscle strength (grid test), forelimb skill (single pellet task), as well as striatal biochemical parameters related to oxidative stress and cellular homeostasis (glutathione peroxidase, glutathione reductase and NADH dehydrogenases activities, lipid peroxidation and TH levels), were evaluated. 6-OHDA infusions did not change locomotor/exploratory activities and muscle strength, as well as the evaluated striatal biochemical parameters. However, 6-OHDA infusions caused significant reductions (50%) in the single pellet reaching task performance, which detects forelimb skill inability and can be used to experimentally identify bradykinesia. Succinobucol partially protected against 6-OHDA-induced forelimb inability. The decreased forelimb ability with no changes in locomotor/exploratory behavior indicates that our 6-OHDA-based protocol represents a useful tool to mechanistically study the dissociation of bradykinesia and hypokinesia in PD.

• 出版日期2016-5-15